Edward Jones has upgraded CVS Health (NYSE:CVS) to buy from hold, citing a potential turnaround in its Aetna insurance business. The investment firm said it believes CVS (NYSE:CVS) will improve its ...

On Thursday, Edward Jones, a financial services firm, upgraded CVS Health (NYSE:CVS) stock from Hold to Buy. The upgrade comes as the stock, which InvestingPro analysis shows is currently ...

As of August 2, 2023, the average one-year price target for CVS Health is 95.96. The forecasts range from a low of 72.72 to a high of $136.50. The average price target represents an increase of 43 ...

Edward Jones upgraded shares of CVS Health (NYSE:CVS – Free Report) from a hold rating to a buy rating in a research note released on Thursday, Marketbeat reports. Several other equities ...

It will take time for CVS to integrate Oak Street into its company, but the long-term trajectory of the deal is promising, said John Boylan, a senior equity analyst for Edward Jones.

New CEO at CVS Begins to Build His Team With a Goal of Reviving the Struggling Health Care Giant AP Health Writer (AP) — CVS Health fell short on third-quarter profit, but it posted strong sales ...

"The new leadership announcement gives us hope that CVS is moving quickly to improve its business execution," said John Boylan at Edward Jones. "However, we also believe that these are the first ...

Edward Jones has upgraded CVS Health (NYSE:CVS) to buy from hold, citing a potential turnaround in its Aetna insurance business. The investment firm said it believes CVS (NYSE:CVS) will improve ...

On Thursday, Edward Jones, a financial services firm, upgraded CVS Health (NYSE:CVS) stock from Hold to Buy. The upgrade comes as the stock, which InvestingPro analysis shows is currently undervalued, ...

(AP) — CVS Health fell short on third-quarter profit, but it posted strong sales and the health care giant shook up leadership under new CEO David Joyner after a rough year that has sent ...